Boston Scientific is keeping the ball rolling in pulsed field ablation, posting 177% electrophysiology growth in the third ...
Boston Scientific (NYSE:BSX) shares were down 5% in morning trading Wednesday following news that the company has paused a ...
In December 2023, Boston Scientific Corporation (NYSE: BSX) initiated the AVANT GUARD trial to evaluate the safety and ...
Demand for the pulsed field ablation device drove the company’s electrophysiology sales up 177% in the third quarter compared ...
GlobalData on MSN3d
FDA greenlights add-ons for Boston Scientific’s Farapulse field ablation systemThe Farawave NAV ablation catheter and the Faraview software are used with the Farapulse field ablation system to provide ...
Analysis of Boston Scientific Corporation's Q3 results, future growth projections, and potential impact of regulatory ...
Boston Scientific collected a set of FDA green lights for an update to its pulsed field ablation system for atrial ...
That was his first sign of AFib. After a failed traditional ablation procedure, Copley was one of the first to have Farapulse — pulse field ablation. “It’s like a smart bomb for heart muscle ...
William Plovanic, an analyst from Canaccord Genuity, maintained the Buy rating on Boston Scientific (BSX – Research Report). The ...
Despite a trial pause, Boston Scientific's impressive Q3 results and strategic expansions hint at a promising growth ...
Boston Scientific Corp. posted another eye-popping quarterly report, led by a 177% year-over-year increase in its ...
SGMC Health recently announced Kamil Hanna, MD, a cardiac electrophysiologist, has successfully performed the first Farapulse ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback